EichorEICHOR
Condition: Lgi1 Encephalitis Synced from ClinicalTrials.gov · August 09, 2026

Recruiting studies: Lgi1 Encephalitis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
Phase N/A · 13 location(s) · University of Bern · NCT05017142
Medium-term Effects of Treatments in Autoimmune Encephalitis
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT07133113
Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease
NA · 1 location(s) · Fundacion Clinic per a la Recerca Biomédica · NCT06515106
Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism
NA · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06079294
Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis
Phase 2 · 17 location(s) · Jena University Hospital · NCT03993262
Efficacy and Safety of Taitacept in Treatment of Refractory or Recurrent Anti-NMDAR/anti-LGI1 Encephalitis
Phase 2 · 1 location(s) · Beijing Tongren Hospital · NCT06510283
A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis
Phase N/A · 1 location(s) · Shen Chun-Hong · NCT06173076
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →